- Investing Ideas
- Global Pharmaceuticals & Biotech Undervalued based on future growth
Global Pharmaceuticals & Biotech Undervalued based on future growth
Results
52
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
52 companies
DongKook Pharmaceutical
Market Cap: ₩822.8b
Produces and sells pharmaceutical products in South Korea and internationally.
A086450
₩18,470.00
7D
-5.1%
1Y
4.9%
Beximco Pharmaceuticals
Market Cap: ৳64.8b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.
BXPHARMA
৳145.30
7D
15.0%
1Y
77.6%
Blau Farmacêutica
Market Cap: R$2.3b
A pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.
BLAU3
R$9.77
7D
-0.9%
1Y
-6.4%
Renata
Market Cap: ৳52.0b
Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh.
RENATA
৳453.20
7D
2.5%
1Y
-5.8%
Clinuvel Pharmaceuticals
Market Cap: AU$519.4m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$10.17
7D
9.9%
1Y
7.7%
Abeona Therapeutics
Market Cap: US$328.9m
A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.
ABEO
US$5.75
7D
1.4%
1Y
-1.0%
SIGA Technologies
Market Cap: US$309.8m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$4.32
7D
-0.5%
1Y
-30.2%
Viva Biotech Holdings
Market Cap: HK$2.4b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$1.10
7D
-6.0%
1Y
-28.6%
Egyptian International Pharmaceutical Industries
Market Cap: ج.م15.0b
Manufactures and sells pharmaceutical ampoules in Egypt and internationally.
PHAR
ج.م89.00
7D
5.3%
1Y
85.3%
JBM (Healthcare)
Market Cap: HK$1.9b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.28
7D
-0.9%
1Y
-26.5%
Essex Bio-Technology
Market Cap: HK$1.5b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$2.64
7D
-2.2%
1Y
-42.7%
Whan In PharmLtd
Market Cap: ₩187.4b
Manufactures and sells various pharmaceutical products in South Korea.
A016580
₩9,810.00
7D
-4.2%
1Y
-17.5%
Daihan PharmaceuticalLtd
Market Cap: ₩149.9b
Engages in the manufacture and sale of therapeutic drugs in South Korea.
A023910
₩25,000.00
7D
-6.9%
1Y
-18.3%
Macrogen
Market Cap: ₩136.0b
Provides precision medicine and bio-engineering healthcare services in Korea and internationally.
A038290
₩12,600.00
7D
-9.5%
1Y
-19.1%
Hyphens Pharma International
Market Cap: S$106.6m
Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.
1J5
S$0.35
7D
6.1%
1Y
12.9%
DreamCIS
Market Cap: ₩87.6b
Operates as a clinical research organization in South Korea.
A223250
₩3,540.00
7D
-7.1%
1Y
-4.2%